Skip to main content
SpringerLink
Log in

Activation of STAT transcription factors in oncogenic tyrosine kinase signaling

  • Review
  • Published:
Journal of Biomedical Science

Abstract

Signal transducers and activators of transcription (STATs) are cytoplasmic transcription factors that translocate to the nucleus and regulate gene expression in response to cytokine and growth factor stimulation. Emerging evidence indicates that STAT signaling is also frequently activated by oncogenes and in tumor cells. Constitutive activation of STAT proteins has been reported in cell lines stably transformed by diverse oncoproteins that directly or indirectly activate specific tyrosine kinase signaling pathways. In addition, STAT activation has been detected in a variety of human tumors and tumor cell lines, many of which are known to harbor activated tyrosine kinases. Recent findings support a model in which activation of STAT signaling in the context of oncogenesis induces gene expression that participates in malignant transformation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Akira S, Nishio Y, Inoue M, Wang X-J, Wei S, Matsukaka T, Yoshida K, Sudo T, Naruto M, Kishimoto T. Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway. Cell 77:63–71;1994.

    Article  PubMed  Google Scholar 

  2. Bharsar D, Cochran BH. Activation of the STAT transcription factor pathway by the Src and PDGF receptor kinases, submitted for publication.

  3. Bonni A, Sun Y, Nadal-Vicens M, Bhatt A, Frank DA, Rozovsky I, Stahl N, Yancopoulos GD, Greenberg ME. Regulation of gliogenesis in the central nervous system by the JAK-STAT signaling pathway. Science 278:477–483;1997.

    Article  PubMed  Google Scholar 

  4. Bromberg JF, Horvath CM, Beser D, Lathem WW, Darnell JE. STAT3 activation enhances cellular transformation by v-Src. Mol Cell Biol, in press.

  5. Bryan TM, Reddel RR. SV40-induced immortalization of human cells. Crit Rev Oncog 5:331–357;1994.

    PubMed  Google Scholar 

  6. Burkhardt AL, Bolen JB, Kieff E, Longnecker R. An Epstein-Barr virus transformation-associated membrane protein interacts with src family tyrosine kinases. J Virol 66:5161–5167;1992.

    PubMed  Google Scholar 

  7. Campbell GS, Yu C-L, Jove R, Carter-Su C. Constitutive activation of JAK1 in Src-transformed cells. J Biol Chem 272:2591–2594;1997.

    Article  PubMed  Google Scholar 

  8. Cao X, Tay A, Guy GR, Tan YH. Activation and association of STAT3 with Src in v-Src-transformed cell lines. Mol Cell Biol 16:1595–1603;1996.

    PubMed  Google Scholar 

  9. Carlesso N, Frank DA, Griffin JD. Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl. J Exp Med 183:811–820;1996.

    Article  PubMed  Google Scholar 

  10. Chai SK, Michols GL, Rothman P. Constitutive activation of JAKs and STATs in BCR-Abl-expressing cell lines and peripheral blood cells from leukemia patients. J Immunol 159:4720–4728;1997.

    PubMed  Google Scholar 

  11. Chaturvedi P, Sharma S, Reddy EP. Abrogation of interleukin-3 dependence of myeloid cells by the v-src oncogene requires SH2 and SH3 domains which specify activation of STATs. Mol Cell Biol 17:3295–3304;1997.

    PubMed  Google Scholar 

  12. Danial NN, Losman JA, Krishnan K, Lu T, Yip N, Krolewski J, Goff SP, Wang JYJ, Rothman PB. Jak1-interacting domain of v-Abl is required for cytokine-independent activation of STATs and proliferation, submitted for publication.

  13. Danial NN, Pernis A, Rothman PB. Jak-STAT signaling induced by the v-abl oncogene. Science 269:1875–1877;1995.

    PubMed  Google Scholar 

  14. Darnell JE. STATs and gene regulation. Science 277:1630–1635;1997.

    Article  PubMed  Google Scholar 

  15. Darnell JE, Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264:1415–1421;1994.

    PubMed  Google Scholar 

  16. Frank DA, Varticovski L. BCR/abl leads to the constitutive activation of Stat proteins, and shares an epitope with tyrosine phosphorylated Stats. Leukemia 10:1724–1730;1996.

    PubMed  Google Scholar 

  17. Fu XY, Zhang JJ. Transcription factor p91 interacts with the epidermal growth factor receptor and mediates activation of the c-fos gene promoter. Cell 74:1135–1145;1993.

    Article  PubMed  Google Scholar 

  18. Fukada T, Hibi M, Yamanaka Y, Takahashi M, Fujitani Y, Yamaguchi T, Nakajima K, Hirano T. Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: Involvement of STAT3 in anti-apoptosis. Immunity 5:449–460;1996.

    Article  PubMed  Google Scholar 

  19. Garcia R, Yu C-L, Hudnall A, Catlett R, Nelson KL, Smithgall T, Fujita EJ, Ethier SP, Jove R. Constitutive activation of STAT3 in fibroblasts transformed by diverse oncoproteins and in breast carcinoma cells. Cell Growth Differ 8:1267–1276;1997.

    PubMed  Google Scholar 

  20. Gobert S, Chretien S, Gouilleux F, Muller O, Pallaed C, Dusanter-Fourt I, Groner B, Lacombe C, Gisselbrecht S, Mayeux P. Identification of tyrosine residues within the intracellular domain of the erythropoietin receptor crucial for STAT5 activation. EMBO J 15:2434–2441;1996.

    PubMed  Google Scholar 

  21. Gouilleux-Gruart V, Gouilleux F, Desaint C, Claisse JF, Capiod JC, Delobel J, Weber-Nordt R, Dusanter-Fourt I, Dreyfus F, Groner B, Prin L. STAT-related transcription factors are constitutively activated in peripheral blood cells from acute leukemia patients. Blood 87:1692–1697;1996.

    PubMed  Google Scholar 

  22. Grandis JR, Drenning SD, Chakraborty A, Zhou MY, Pitt A, Tweardy DJ. Requirement of STAT3 but not STAT1 activation for EGFR mediated cell growth, submitted for publication.

  23. Hanratty WP, Dearolf CR. The Drosophila tumorous-lethal hematopoietic oncogene is a dominant mutation in the hopscotch locus. Mol Gen Genet 238:33–37;1993.

    PubMed  Google Scholar 

  24. Hauser PJ, Pledger WJ. STAT3 activation is linked to p27kip1 induction in differentiating keratinocytes, submitted for publication.

  25. Hou XS, Melnick MB, Perrimon N. Marelle acts downstream of the Drosophila HOP/JAK kinase and encodes a protein similar to the mammalian STATs. Cell 84:411–419;1996.

    Article  PubMed  Google Scholar 

  26. Ihle JN. STATs: Signal transducers and activators of transcription. Cell 84:331–334;1996.

    Article  PubMed  Google Scholar 

  27. Ilaria RL, Van Etten RA. P210 and P190(BCR/ABL) induce the tyrosine phosphorylation and DNA binding activity of multiple specific STAT family members. J Biol Chem 271:31704–31710;1996.

    Article  PubMed  Google Scholar 

  28. Kaplan MH, Sun YL, Hoey T, Gusby MJ. Impaired IL-12 responses and enhanced development of Th2 cells in STAT4-deficient mice. Nature 380:627–630;1996.

    Article  PubMed  Google Scholar 

  29. Leaman DW, Leung S, Li X, Stark GR. Regulation of STAT-dependent pathways by growth factors and cytokines. FASEB J 10:1578–1588;1996.

    PubMed  Google Scholar 

  30. Leaman DW, Pisharody S, Flickinger TW, Commane MA, Schlessinger J, Kerr IM, Levy DE, Stark GR. Roles of JAKs in activation of STATs and stimulation of c-fos gene expression by epidermal growth factor. Mol Cell Biol 16:369–375;1996.

    PubMed  Google Scholar 

  31. Liu RY, Fan C, Garcia R, Jove R, Zuckerman KS. Constitutive activation of JAK2/STAT5 signal transduction pathway in growth factor-independent megakaryocytic leucemic cell lines, submitted for publication.

  32. Lund TC, Garcia R, Medveczky MM, Jove R, Medveczky PG. Activation of STAT transcription factors by herpesvirus Saimiri T1p-484 requires p56lck. J Virol 71:6677–6682;1997.

    PubMed  Google Scholar 

  33. Migone TS, Lin JX, Cereseto A, Mulloy JC, O'Shea JJ, Franchini G, Leonard WJ. Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-I. Science 269:79–81;1995.

    PubMed  Google Scholar 

  34. Mui AL-F, Wakao H, Kinoshita T, Kitamura T, Miyajima A. Suppression of interleukin-3 induced gene expression by a c-terminal truncated STAT5: Role of STAT5 in proliferation. EMBO J 15:2425–2433;1996.

    PubMed  Google Scholar 

  35. Nelson KL, Bowman TL, Jove R, Smithgall TE. Direct activation of STAT3 by the c-Fes protein-tyrosine kinase. J Biol Chem, in press.

  36. Nielsen M, Kaltoft K, Nordahl M, Ropke C, Geisler C, Mustelin T, Dobson P, Svejgaard A, Odum N. Constitutive activation of a slowly migrating isoform of STAT3 in mycosis fungoides: tyrphostin AG490 inhibits STAT3 activation and growth of mycosis fungoides tumor cell lines. Proc Natl Acad Sci USA 94:6764–6769;1997.

    Article  PubMed  Google Scholar 

  37. Ruff-Jamison S, Chen K, Cohen S. Induction by EGF and interferon-γ of tyrosine phosphorylated DNA binding proteins in mouse liver nuclei. Science 261:1733–1736;1993.

    PubMed  Google Scholar 

  38. Sartor CI, Dziubinski ML, Yu CL, Jove R, Ethier SP. Role of epidermal growth factor receptor and STAT-3 activation in autonomous proliferation of SUM-102PT human breast cancer cells. Cancer Res 57:978–987;1997.

    PubMed  Google Scholar 

  39. Schindler C, Darnell JE. Transcriptional responses to polypeptide ligands: The JAK-STAT pathway. Annu Rev Biochem 64:621–651;1995.

    Article  PubMed  Google Scholar 

  40. Shimozaki K, Nakajima K, Hirano T, Nagata S. Involvement of STAT3 in the granulocyte colony-stimulating factor-induced differentiation of myeloid cells. J Biol Chem 272:25184–25189;1997.

    Article  PubMed  Google Scholar 

  41. Shuai K, Halpern J, ten Hoeve J, Rao X, Sawyers CL. Constitutive activation of STAT5 by the BCR-ABL oncogene in chronic myelogenous leukemia. Oncogene 13:247–254;1996.

    PubMed  Google Scholar 

  42. Shuai K, Halpern J, ten Hoeve J, Rao X, Sawyers CL. Constitutive activation of STAT5 by the BCR-ABL oncogene in chronic myelogenous leukemia. Oncogene 13:247–254;1996.

    PubMed  Google Scholar 

  43. Suematsu S, Matsusaka T, Matsuda T, Ohno S, Miyazaki J, Yamamura K, Hirano T. Generation of plasmacytomas with the chromosomal translocation t(12;15) in interleukin 6 transgenic mice. Proc Natl Acad Sci USA 89:232–235;1992.

    PubMed  Google Scholar 

  44. Sun WH, Pabon C, Alsayed Y, Huang PP, Jandeska S, Uddin S, Platanias LC, Rosen ST. Interferon-alpha resistance in cutaneous T cell lymphoma cell line is associated with lack of STAT1 expression, submitted for publication.

  45. Takeda K, Noguchi K, Shi W, Tanaka T, Matsumoto M, Yoshida N, Kishimoto T, Akira S. Targeted disruption of the mouse STAT3 gene leads to early embryonic lethality. Proc Natl Acad Sci USA 15:3801–3804;1997.

    Article  Google Scholar 

  46. Takeda K, Tanaka T, Shi W, Matsumoto M, Minami M, Kashiwamura SI, Nakanishi K, Yoshida N, Kishimoto T, Akira S. Essential role of STAT6 in IL-4 signaling. Nature 380:627–630;1996.

    Article  PubMed  Google Scholar 

  47. Thirfelder WE, van Deursen JM, Yamamoto K, Tripp RA, Sarawar SR, Carson RT, Sangster MY, Vignali DAA, Doherty PC, Grosveld GC, Ihle JN. Requirement for STAT4 in interleukin-12-mediated responses of natural killer and T cells. Nature 382:171–174;1996.

    Article  PubMed  Google Scholar 

  48. Turkson J, Bowman T, Garcia R, Caldenhoven E, de Groot RP, Jove R. STAT3 activation by Src induces specific gene regulation and is required for cell transformation. Mol Cell Biol, in press.

  49. Vignais M-L, Sadowski HB, Watling D, Rogers NC, Gilman M. Platelet-derived growth factor induces phosphorylation of multiple JAK family kinases and STAT proteins. Mol Cell Biol 16:1759–1769;1996.

    PubMed  Google Scholar 

  50. Wagner BJ, Hayes TE, Hoban CJ, Cochran BH: The SIF binding element confers sis/PDGF inducibility onto the c-fos promoter. EMBO J 9:4477–4484;1990.

    PubMed  Google Scholar 

  51. Wang Y-Z, Garcia R, Jove R, Pledger WJ. Direct association of PDGF receptor and STAT3 in 3T3 fibroblasts induced by platelet-derived growth factor, submitted for publication.

  52. Watson CJ, Miller WR. Elevated levels of members of the STAT family of transcription factors in breast carcinoma nuclear extracts. Br J Cancer 71:840–844;1995.

    PubMed  Google Scholar 

  53. Weber-Nordt RM, Egen C, Wehinger J, Ludwig W, Gouilleux-Gruart V, Mertelsmann R, Finke J. Constitutive activation of STAT proteins in primary lymphoid and myeloid leukemia cells and in Epstein-Barr virus (EBV)-related lymphoma cell lines. Blood 88:809–816;1996.

    PubMed  Google Scholar 

  54. Weber-Nordt RM, Egen C, Wehinger J, Ludwig W, Gouilleux-Gruart V, Mertelsmann R, Finke J. Constitutive activation of STAT proteins in primary lymphoid and myeloid leukemia cells and in Epstein-Barr virus (EBV)-related lymphoma cell lines. Blood 88:809–816;1996.

    PubMed  Google Scholar 

  55. Yu C-L, Jove R, Burakoff SJ. Constitutive activation of the Jak-STAT pathway in T lymphoma overexpressing the lck protein tyrosine kinase. J Immunol, in press.

  56. Yu, C-L, Meyer DJ, Campbell GS, Larner AC, Carter-Su C, Schwartz J, Jove R. Enhanced DNA-binding activity of a STAT3-related protein in cells transformed by the Src oncoprotein. Science 269:81–83;1995.

    PubMed  Google Scholar 

  57. Zhang Q, Nowak I, Vonderheid EC, Rook AH, Kadin ME, Nowell PC, Shaw LM, Wasik MA. Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome. Proc Natl Acad Sci USA 93:9148–8153;1996.

    Article  PubMed  Google Scholar 

  58. Zhong Z, Wen Z, Darnell JE. Stat3: A STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 264:95–98;1994.

    Google Scholar 

  59. Zong C, Yan R, August A, Darnell JE, Hanafusa H. Unique signal transduction of Eyk: Constitutive stimulation of the JAK-STAT pathway by an oncogenic receptor-type tyrosine kinase. EMBO J 15:4515–4525;1996.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Molecular Oncology Program, H. Lee Moffitt Cancer Center and Research Institute, Department of Biochemistry and Molecular Biology, University of South Florida College of Medicine, Tampa, Fla., USA

    Roy Garcia &  Richard Jove

Authors
  1. Roy Garcia
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Richard Jove
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Garcia, R., Jove, R. Activation of STAT transcription factors in oncogenic tyrosine kinase signaling. J Biomed Sci 5, 79–85 (1998). https://doi.org/10.1007/BF02258360

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02258360

Key Words

Search

Navigation